Shenwei Pharmaceutical Co., Ltd., a young, open and energetic large-scale modern Chinese medicine industry group, is one of the top 1 pharmaceutical companies in China and the top five proprietary Chinese medicines, and is the largest pharmaceutical company with the market value on the Hong Kong Stock Exchange. It has won hundreds of honorary titles, such as the most growing independent brand enterprise in the industry, the May 1 Labor Medal, and the national advanced unit for implementing customer satisfaction projects. As an industry model of modern Chinese medicine quality control, Shenwei Pharmaceutical has been praised by National Medical Products Administration for many times and recommended and reported to the central media for many times.

In p>22 and 21, "Shenwei" and "Five Blessingg" were successively recognized as well-known trademarks in China by the state. In 23, Shenwei Pharmaceutical passed the national GMP certification in an all-round way; In 24, it obtained the (IMS) certificate issued by British Standards Institute (BSI), and took the lead in passing the international standard certification of integrated management of quality management system (ISO91), environmental management system (ISO141) and occupational safety and health management system (OHSAS181). In 26, it passed the GMP certification of TGA in Australia. The workshop has been recognized by more than 2 countries of PIC/S, such as Britain, Germany and France.

Modern Technology and Quality Center has passed the national laboratory certification. Shenwei Pharmaceutical has built the only high-tech industrialization demonstration project of advanced process integration and automatic control of production process of traditional Chinese medicine preparations and the demonstration project of quality standardization of traditional Chinese medicine injections in China. It has become a national demonstration base for high-tech industrialization of traditional Chinese medicine preparations and a national 863 achievement industrialization base. Shenwei Pharmaceutical focuses on the three fast-growing target markets of middle-aged and elderly people, children and antiviral drugs, focusing on the development of new dosage forms and new products of modern Chinese medicine, and has formed a strong product portfolio featuring three dosage forms of modern Chinese medicine injections, modern Chinese medicine soft capsules and modern Chinese medicine granules.